temozolomide has been researched along with cudc-907 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| deCarvalho, AC; Mikkelsen, T; Quartararo, CE; Reznik, E; Stockwell, BR | 1 |
| Fu, RG; Liao, DF; Sheng, WB; Sun, Y | 1 |
1 review(s) available for temozolomide and cudc-907
| Article | Year |
|---|---|
Designing multi-targeted agents: An emerging anticancer drug discovery paradigm.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Humans; Molecular Structure; Phosphotransferases; Protein Kinase Inhibitors; Structure-Activity Relationship | 2017 |
1 other study(ies) available for temozolomide and cudc-907
| Article | Year |
|---|---|
High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma.
Topics: | 2015 |